Amanda Silva Brun

Amanda Silva Brun is an accomplished professional with extensive experience in innovation and biotherapy. Currently serving as Chargée de Mission for Innovation académique at Secrétariat général pour l'investissement and as an Invited Member of the Harvard Business Review Advisory Council, Amanda also contributes as a scientific board member for Région Île-de-France. As a co-founder of both Evora Biosciences and EVerZom, Amanda has been instrumental in advancing research and development in these sectors. Additionally, Amanda has held a pivotal role at CNRS - Centre national de la recherche scientifique, first as a researcher and now as Director of Research since 2022. In the nanomedicine field, Amanda is an honorary member of the SOCIETE FRANCAISE DE NANOMEDECINE, having served as Vice-President from 2021 to 2022 and as a board member since 2013.